PARP Inhibition in Prostate Cancer: An Evolving Paradigm and the Role of the Practicing Urologist

Download slides and watch an on-demand webcast featuring an expert urologist and medical oncologist on how urologists can implement best practices for testing and identifying patients with prostate cancer likely to benefit from PARP inhibitor&ndash based monotherapy and combination therapy.

Share

Program Content

Activities

PARPi Patient Selection
Selecting Patients for PARP Inhibitor Therapy: Principles of Genetic Testing
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2022

Expires: October 16, 2023

View Activity
PARPi for Prostate Cancer
Current Use of PARP Inhibitors in Prostate Cancer: Rationale and Key Data
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2022

Expires: October 16, 2023

View Activity

Activities

PARPi in PCa for Urology
PARP Inhibition in Prostate Cancer: An Evolving Paradigm and the Role of the Practicing Urologist
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2022

Expires: November 29, 2023

View Activity

Faculty

cover img faculity

Stephen Freedland, MD

Professor
Department of Surgery
Department of Urology
Cedars-Sinai Medical Center
Los Angeles, California
Staff Physician
Durham VA Medical Center
Durham, North Carolina

cover img faculity

Rana R. McKay, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
University of California, San Diego
Genitourinary Oncology Team Lead
Moores Cancer Center
La Jolla, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC